Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. (Q46653304)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2005

Language	Label	Description	Also known as
English	Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.	scientific article published in October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

object named as

Hyman B Muss

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

4

object named as

Paul J Hesketh

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jørn Herrstedt

1

object named as

Jørn Herrstedt

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Harry Raftopoulos

6

object named as

Harry Raftopoulos

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Steven M Grunberg

7

object named as

Steven M Grunberg

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

8

object named as

Munir Gabriel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Carolyn M Hustad

10

object named as

Carolyn M Hustad

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Franck Skobieranda

12

object named as

Franck Skobieranda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

David G Warr

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Peter D Eisenberg

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Anthony Rodgers

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Aprepitant Moderately Emetogenic Chemotherapy Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1548-1555

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16104039%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for classifying the acute emetogenicity of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

The pattern of emesis following high-dose cyclophosphamide and the anti-emetic efficacy of ondansetron

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute emesis: moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed emesis: moderately emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21343

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46653304&oldid=2105033349"